NW
Northwest Biotherapeutics, Inc.
NWBO · OTC
$0.16 -0.09% (-$0.00)
1M -7.99%
Market Cap $261.8M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 120.47x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 6.45%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 36.95%
Net margin 1,751.63%
Op. margin 2,316.11%
Quality
0 /100
Poor ROIC 136.63%
ROA 50.12%
Asset turnover 0.03x
Debt
0 /100
High Current ratio 0.04x
Int. coverage -6.81x
Debt/Equity N/A
Stability
48 /100
Moderate Beta -0.61x
Rev. volatility 21.96%
EPS volatility 30.94%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o NWBO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Linda F. Powers
Employees
105
Headquarters
Bethesda
Nadchodzące wydarzenia
12 LIS
Earnings
Upcoming earnings report